Westlake Chemical Partners LP
Description
Westlake Chemical Partners LP acquires, develops, and operates ethylene production facilities and related assets in the United States. The company's ethylene production facilities primarily convert ethane into ethylene. It also sells ethylene co-products, such as propylene, crude butadiene, pyrolysis gasoline, and hydrogen directly to third parties on either a spot or contract basis. Westlake Chemical Partners GP LLC serves as the general partner of the company. Westlake Chemical Partners LP was founded in 1991 and is headquartered in Houston, Texas.
About
CEO
Mr. Jean-Marc Gilson
Employees
0
Instrument type
Limited Partnership
Sector
Basic Materials
Industry
Chemicals
MIC code
XNYS
Address
2801 Post Oak Boulevard, Houston, TX 77056, United States
×
![Enlarged Chart]()
Oscillators
No data available
Summary
No data available
Moving Averages
No data available
Earnings
| Date | Estimate EPS | Actual EPS | Difference | % Surprise |
|---|---|---|---|---|
| Nov 3, 2025 | — | — | — | — |
| Aug 4, 2025 | — | — | — | — |
| Apr 29, 2025 | — | — | — | — |
| Feb 18, 2025 | 0.37 | — | — | — |
| Nov 5, 2024 | 0.40 | 0.51 | 0.11 | 27.50% |
Earnings estimate
|
Next Quarter
(Mar 2025)
|
Next Year
(Dec 2025)
|
|||
|---|---|---|---|---|
| Number of analysts | — | 2 | — | 3 |
| Average estimate | — | 0.43 | — | 1.69 |
| Low estimate | — | 0.37 | — | 1.64 |
| High estimate | — | 0.49 | — | 1.73 |
| Last year EPS | — | 0.42 | — | 1.61 |
[stock_revenue_estimate]
Growth estimates
Current qtr
-8.900%
Next qtr. (Mar 2025)
1.790%
Current year
4.750%
Next year (Dec 2025)
4.720%
Next 5 years (per annum)
—
Past 5 years (per annum)
—
Income statement
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Fiscal date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Total reported revenue | 1.19B | 1.59B | 1.21B | 966.67M | 1.09B |
| Cost of revenue | 803.33M | 1.22B | 773.15M | 587.79M | 712.44M |
| Gross profit | 387.46M | 377.37M | 441.71M | 378.88M | 379.43M |
| Operating expense | |||||
| Research & development | — | — | — | — | — |
| Selling general and admin | 29.75M | 29.68M | 31.02M | 25.90M | 29.28M |
| Other operating expenses | — | — | — | — | — |
| Operating income | 357.71M | 347.69M | 410.69M | 352.99M | 350.15M |
| Non operating interest income | |||||
| Income | — | — | — | — | — |
| Expense | 26.50M | 13.41M | 8.82M | 12.04M | 19.62M |
| Other income expense | 4.23M | 1.57M | 62,000 | 733,000 | 3.10M |
| Pretax income | 335.44M | 335.85M | 401.93M | 341.68M | 333.62M |
| Tax provision | 813,000 | 1.02M | 549,000 | 564,000 | 728,000 |
| Net income | 334.63M | 334.83M | 401.39M | 341.12M | 332.90M |
| Basic EPS | 1.54 | 1.82 | 2.34 | 1.88 | 1.77 |
| Diluted EPS | 1.54 | 1.82 | 2.34 | 1.88 | 1.77 |
| Basic average shares | 35.25M | 35.26M | 35.28M | 35.20M | 34.45M |
| Diluted average shares | 35.25M | 35.26M | 35.28M | 35.20M | 34.45M |
| EBITDA | 472.14M | 470.33M | 519.56M | 456.88M | 460.57M |
| Net income from continuing op. | 334.63M | 334.83M | 401.39M | 341.12M | 332.90M |
| Minority interests | -280.34M | -270.66M | -318.84M | -274.95M | -271.91M |
| Preferred stock dividends | — | — | — | — | — |
Balance sheet
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Fiscal date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Total assets | 1.32B | 1.37B | 1.48B | 1.36B | 1.39B |
| Current assets | |||||
| Cash | — | — | — | — | — |
| Cash equivalents | — | — | — | — | — |
| Cash and cash equivalents | 58.62M | 64.78M | 17.06M | 17.15M | 19.92M |
| Other short term investments | — | — | — | — | — |
| Accounts receivable | 15.34M | 18.53M | 5.83M | 11.03M | 9.25M |
| Other receivables | 3.36M | 1.50M | — | 123.23M | 660,000 |
| Inventory | 4.43M | 4.72M | 8.90M | 3.47M | 2.48M |
| Prepaid assets | — | — | 396,000 | 392,000 | 470,000 |
| Restricted cash | — | — | — | — | — |
| Assets held for sale | — | — | — | — | — |
| Hedging assets | — | — | — | — | — |
| Other current assets | 442,000 | 305,000 | 396,000 | — | — |
| Non current assets | |||||
| Properties | 112.21M | 110.98M | 107.66M | 106.08M | 97.40M |
| Land and improvements | — | — | — | — | — |
| Machinery furniture equipment | 1.94B | 1.94B | 1.91B | 1.86B | 1.83B |
| Construction in progress | 37.75M | 26.04M | 30.75M | 42.25M | 45.60M |
| Leases | — | — | — | — | — |
| Accumulated depreciation | -1.16B | -1.10B | -1.02B | -971.48M | -882.77M |
| Goodwill | 11.63M | 11.63M | 11.63M | 11.63M | 11.63M |
| Investment properties | — | — | — | — | — |
| Financial assets | — | — | — | — | — |
| Intangible assets | — | — | — | — | — |
| Investments and advances | — | — | — | — | — |
| Other non current assets | 140.98M | 130.16M | 150.14M | 36.69M | 46.24M |
| Total liabilities | 460.59M | 468.27M | 508.00M | 441.35M | 441.32M |
| Current liabilities | |||||
| Accounts payable | 31.36M | 49.40M | 45.90M | 20.99M | 21.34M |
| Accrued expenses | 16.47M | 10.93M | 60.90M | 18.77M | 17.51M |
| Short term debt | — | — | — | — | — |
| Deferred revenue | — | — | — | — | — |
| Tax payable | 3.03M | 2.65M | — | — | — |
| Pensions | — | — | — | — | — |
| Other current liabilities | 5.48M | 3.96M | — | — | — |
| Non current liabilities | |||||
| Long term debt | 399.67M | 399.67M | 399.67M | 399.67M | 399.67M |
| Provision for risks and charges | — | — | — | — | — |
| Deferred liabilities | 1.63M | 1.66M | 1.53M | 1.54M | 1.65M |
| Derivative product liabilities | — | — | — | — | — |
| Other non current liabilities | 2.95M | — | — | 381,000 | 1.15M |
| Shareholders equity | |||||
| Common stock | — | — | — | — | — |
| Retained earnings | — | — | — | — | — |
| Other shareholders equity | — | — | — | — | — |
| Total shareholders equity | 856.25M | 903.71M | 972.70M | 915.14M | 952.14M |
| Additional paid in capital | — | — | — | — | — |
| Treasury stock | — | — | — | — | — |
| Minority interest | 576.32M | 611.78M | 678.72M | 637.74M | 674.62M |
Cash flow statement
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||
| Net Income | 334.63M | 334.83M | 401.39M | 341.12M | 332.90M | 330.57M | 353.06M | 353.40M | 353.85M | 509.82M | 546.55M | 395.92M | 246.97M |
| Depreciation | 110.20M | 121.07M | 108.81M | 103.15M | 107.32M | 108.84M | 113.99M | 98.21M | 81.21M | 77.61M | 73.46M | 64.26M | 57.19M |
| Deferred Taxes | — | — | — | — | — | — | — | 344,000 | -456,000 | 8.61M | 37.05M | -8.10M | -1.86M |
| Stock-Based Compensation | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other Non-Cash Items | -27,000 | 356,000 | -276,000 | -269,000 | -459,000 | -347,000 | -1.04M | 738,000 | -286,000 | — | — | — | — |
| Accounts Receivable | 28.66M | 59.76M | -26.29M | -72.93M | 9.29M | 1.03M | 78.51M | -91.29M | 13.59M | -42.61M | 14.35M | 13.61M | -29.85M |
| Accounts Payable | 1.57M | -17.00M | 19.78M | 4.25M | 421,000 | -4.48M | 1.44M | -2.18M | 836,000 | -4.92M | 7.36M | -34.94M | 17.23M |
| Other Assets & Liabilities | -31.86M | -2.55M | -136.75M | -4.68M | -62,000 | 714,000 | -11.57M | -77.97M | -733,000 | 33.27M | -57.61M | 44.99M | -33.51M |
| Operating Cash Flow | 443.18M | 496.47M | 366.67M | 370.65M | 449.41M | 436.33M | 534.38M | 281.26M | 448.01M | 581.79M | 621.16M | 475.75M | 256.17M |
| Investing Activities | |||||||||||||
| Capital Expenditures | -46.82M | -54.12M | -81.17M | -36.97M | -43.71M | -39.86M | -68.86M | -299.64M | -231.19M | -202.82M | -223.13M | -158.44M | -73.68M |
| Net Intangibles | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net Acquisitions | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Purchase of Investments | -174.12M | -319.88M | -276.00M | -349.00M | -529.45M | -384.00M | -199.00M | — | — | — | — | — | — |
| Sale of Investments | 145.00M | 362.00M | 293.00M | 388.00M | 515.45M | 372.05M | 62.83M | — | — | — | — | — | — |
| Investing Cash Flow | -75.94M | -12.00M | -64.30M | 2.03M | -57.71M | -51.81M | -203.23M | -299.48M | -231.19M | -202.82M | -223.13M | -158.44M | -71.57M |
| Financing Activities | |||||||||||||
| Long-Term Debt Issuance | 209.25M | 32.00M | — | — | 123.51M | 3.65M | 165.26M | 212.18M | 291.71M | 181.64M | 231.07M | — | — |
| Long-Term Debt Payments | -209.25M | -32.00M | — | — | -201.45M | — | -285.93M | -1.55M | -135.34M | -78.94M | — | — | — |
| Other Financing Charges | -315.81M | -337.60M | -277.86M | -311.84M | -315.56M | -341.89M | -343.93M | -244.59M | -310.84M | -51.66M | — | — | — |
| Financing Cash Flow | -382.23M | -404.01M | -344.24M | -378.20M | -392.92M | -391.60M | -396.02M | -68.90M | -185.55M | -267.31M | -372.46M | -338.81M | -197.08M |
| Other Cash Details | |||||||||||||
| End Cash Position | 58.62M | 64.78M | 17.06M | 17.15M | 19.92M | 19.74M | 27.01M | 88.90M | 169.56M | 133.75M | — | — | — |
| Income Tax Paid | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Interest Paid | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Free Cash Flow | 405.18M | 409.62M | 327.27M | 336.43M | 407.10M | 396.29M | 468.50M | -11.91M | 221.36M | 401.19M | 379.38M | 338.38M | 195.04M |
Error: Invalid format in Holders JSON file.
Article
Westlake Chemical Partners Announce Fourth Quarter and Full Year 2024 Earnings Conference Call
HOUSTON--(BUSINESS WIRE)--Westlake Chemical Partners (NYSE: WLKP) will release its fourth quarter and full year 2024 earnings prior to the market opening on Monday, February 24, 2025. The company will host a conference call at 1:00 p.m. Eastern Time (12:00 p.m. Central Time) on the same day to discuss the earnings release. To access the conference by phone, it is necessary to pre-register at https://register.vevent.com/register/BI294ab16856704d199e4792cc3d8bb4b0. Once registered, you will recei.
Feb 10, 2025
Article
Westlake Chemical Partners LP Announces Fourth Quarter 2024 Distribution
HOUSTON--(BUSINESS WIRE)--The Board of Directors of Westlake Chemical Partners GP LLC, the general partner of Westlake Chemical Partners LP (the "Partnership") (NYSE:WLKP), has declared a distribution of $0.4714 per unit. This is the 42nd quarterly distribution announced by the Partnership since its initial public offering. The distribution will be payable on February 25, 2025, to unit holders of record on February 7, 2025. This release is intended to be a qualified notice under Treasury Regula.
Jan 27, 2025
Article
Undercovered Dozen: Asbury Automotive, Globalstar, Northland Power, Aquestive Therapeutics +
The 'Undercovered' Dozen series highlights 12 lesser-covered stocks, offering fresh investment ideas and sparking community discussions on their potential. Xometry's AI-driven procurement software in a specialized B2B marketplace shows high-growth potential to Bert Hochfeld, making it a promising investment. Grassroots Trading argues that Boston Scientific's acquisition of Axonics enhances its urology offerings, positioning it strongly in the sacral neuromodulation field.
Nov 9, 2024
